Optometry News

According to the CDC, H5N1 bird flu has caused recent outbreaks in poultry and dairy cows, with a total of four human cases reported among U.S. dairy and poultry workers. In at least two cases, the only reported symptom was red eyes.

The FDA approved FYB203/Ahzantive as a biosimilar to Eylea, according to a joint press release from Formycon and Klinge Biopharma.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Thomas Aaberg Jr., MD, of Neurotech Pharmaceuticals, discusses NT-501, an encapsulated cell therapy in development for macular telangiectasia type 2.

To combat the myriad of stressors in life, taking a break to plug into your inner joy opens the door to increased well-being.

KIAWAH ISLAND, S.C. — A study presented at Kiawah Eye found no difference in surgical outcomes between endoscopic and external dacryocystorhinostomy in adults and children with nasolacrimal duct obstruction.

As a past president of the Pennsylvania Optometric Association, I am very familiar with how our profession expands its scope of practice.

Digital health company Luminopia Inc. announced real-world data from the Patients Using Prescription Luminopia Registry, which demonstrated the efficacy of its binocular, virtual reality-based medical device for children with amblyopia.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, David Kirn, MD, of 4D Molecular Therapeutics provides an update on two candidates for retinal diseases.

Given the substantial investment to become a practicing physician, it should not be surprising that the most significant asset of most physicians is their ability to practice their profession.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Michael Singer, MD, of the University of Texas Health Science Center, discusses 36-month data investigating Yutiq for chronic noninfectious uveitis.